D-0424-2017 Class III Terminated

Recalled by Pfizer Inc. — New York, NY

FDA drug recall D-0424-2017 was initiated by Pfizer Inc. on Sep 9, 2016 and is designated Class III. Reason for recall: Failed Impurities/Degradations Specifications; Out of specification results for two known degradation products and total impurities at 18 months The recall status is terminated (terminated Aug 18, 2017). Affected quantity: 1,706 cartons.

Recall details

Product Type
Drugs
Report Date
Jan 18, 2017
Initiation Date
Sep 9, 2016
Termination Date
Aug 18, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,706 cartons

Product description

Cytotec (misoprostol) Tablets, 200 mcg, 100 Tablets blister pack (10X10), For in-institution use only, Rx only, Distributed by G.D. Searle, Division of Pfizer, Inc., NY, NY --- NDC 0025-1461-34

Reason for recall

Failed Impurities/Degradations Specifications; Out of specification results for two known degradation products and total impurities at 18 months

Distribution pattern

Nationwide

Code information

1) Lot # B08493 - Expiration Date 12/2016; 2) Lot # B13230 - Expiration Date 08/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0424-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0424-2017. Report a data issue: hello@regdatalab.com.